| 4.51 -0.03 (-0.66%) | 02-14 15:57 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 10.12 | 1-year : | 13.43 |
| Resists | First : | 8.66 | Second : | 11.5 |
| Pivot price | 5.55  |
|||
| Supports | First : | 4.07 | Second : | 3.39 |
| MAs | MA(5) : | 4.59 |
MA(20) : | 6.96 |
| MA(100) : | 10.15 |
MA(250) : | 10.52 |
|
| MACD | MACD : | -1.7  |
Signal : | -1.6 |
| %K %D | K(14,3) : | 7.1 |
D(3) : | 7.5 |
| RSI | RSI(14): 23.1 | |||
| 52-week | High : | 12.02 | Low : | 4.07 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ LGST ] has closed above bottom band by 34.3%. Bollinger Bands are 378.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 31 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 5.4 - 5.43 | 5.43 - 5.45 |
| Low: | 4.45 - 4.48 | 4.48 - 4.5 |
| Close: | 4.47 - 4.51 | 4.51 - 4.54 |
Semper Paratus Acquisition Corporation does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the transportation, supply chain, and logistics industries. The company was incorporated in 2021 and is based in New York, New York.
Wed, 14 Feb 2024
Tevogen Bio Holdings Inc., a Cell Therapy Company, Announces Completion of Business Combination and is to be ... - Marketscreener.com
Wed, 14 Feb 2024
Semper Paratus Acquisition Corp: Strategic Post-Merger Agreements Set - TipRanks.com - TipRanks
Tue, 13 Feb 2024
Tevogen Bio Inc completed the acquisition of Semper Paratus Acquisition Corporation from a group of shareholders in ... - Marketscreener.com
Fri, 02 Feb 2024
Semper Paratus Shareholders Approve Tevogen Bio Merger - TipRanks.com - TipRanks
Thu, 01 Feb 2024
Semper Paratus shareholders approve business combination with Tevogen - TipRanks.com - TipRanks
Tue, 05 Dec 2023
With a 56% stake, Semper Paratus Acquisition Corporation (NASDAQ:LGST) insiders have a lot riding on the company - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Shell Companies
|
|
| Shares Out | 15 (M) |
| Shares Float | 6 (M) |
| Held by Insiders | 88.9 (%) |
| Held by Institutions | 20.1 (%) |
| Shares Short | 3 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0.09 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.02 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -0.7 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -1 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 50.11 |
| PEG Ratio | 0 |
| Price to Book value | -4.43 |
| Price to Sales | 0 |
| Price to Cash Flow | -96.74 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|